Despite the impressive pace of prion research in recent years, many important issues remain unresolved and new forms of prion disease continue to emerge. In this special issue of the BBA-Molecular Basis of Disease series, we have assembled a combination of important mini-reviews and research papers from leaders in the field of prion research. The result is a snapshot that not only summarizes recent progress in the field but also points to the remaining unresolved issues in prion biology that will shape future developments.
Although much progress has been made in understanding the origins and spread of bovine spongiform encephalopathy (BSE), it will be some years before the full impact on human health can be predicted with confidence. Jonathan Wadsworth and John Collinge have been at the forefront of attempts to understand the relationship between BSE and human prion disease. The recognition that variant Creutzfeldt-Jakob disease and BSE are caused by the same prion strain as well as the apparently protean nature of BSE prions has dramatically highlighted the need for a precise understanding of the molecular biology of human and animal prion diseases. The zoonotic potential of BSE prions highlights the importance of human exposure to prions from other sources. Of particular concern is the emergence of chronic wasting disease (CWD) of deer, elk, and moose in North America. Although BSE and CWD appear to be teleologically unrelated, the connection of CWD to other animal prion diseases, in particular scrapie in sheep and goats, remains obscure. In addition, previously unrecognized forms of scrapie appear, like CWD, to be emerging. CWD is reviewed by Christina Sigurdson and Adriano Aguzzi, while Nora Hunter summarizes the biology of classical and atypical scrapie. Relevant to the issue of unpredictable interspecies prion transmission is the issue of prion strains, which remain one of the most challenging problems for the prion hypothesis. Rodrigo Morales, Karim Abid, and Claudio Soto review the in vivo and molecular approaches that illustrate the changeable nature of prion strains as they transit species barriers.
The physiological function of the normal form of the prion protein remains unclear and it is uncertain whether loss of this function contributes to prion pathogenesis. In their review, Laura Westergard, Heather Christensen, and David Harris summarize the major proposed functions for PrP C and outline how loss of neuroprotective PrP C might contribute to prion pathogenesis. Along these lines Karah Nazor, Tanya Seward and I detail the results of new studies that show behavioral and neuropathological deficits in PrP knockout mice. An increasingly important aspect of prion pathology revolves around additional prion protein gene family members, namely Doppel, and the newly described relative, Shadoo, which has overlapping functional activity with PrP C . Joel Watts and David Westaway review studies describing the functional interrelationships of these proteins, the continued study of which will likely shed light on the function of PrP C and the neurotoxic pathways that are initiated during prion disease.
Studies involving the manipulation of PrP genes by transgenesis in mice have provided crucial insights into the mechanism of prion propagation and the pathogenesis of prion diseases. Jean Manson and her colleagues describe recent advances using elegant gene targeting approaches in which specific mutations have been introduced into the endogenous murine PrP genes including glycosylation-defective mutants, pathogenic point mutations, disease modulating polymorphisms, and the effects of expressing different primary structures of PrP from different species on disease susceptibility. In concert with powerful in vivo approaches to studying prion diseases, recent years have witnessed the apparent generation of prion infectivity from PrP synthesized in non-mammalian systems as well as the development of cell-free systems in which to study prion conversion. Ilia Baskakov and Leonid Breydo summarize describe the strategies and challenges related to the de novo generation of synthetic mammalian prions, while Leila Kupfer, Martin Groschup, and colleagues describe the results of new experiments showing that PrP conversion depends on a combination of PrP amino acid sequence and prion strain properties.
I extend my warm thanks to the authors, researchers, and editorial staff who contributed their time and efforts to this special issue.
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